Impulse Control Disorders Following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: Clinical Aspects

Parkinson's disease (PD) has been associated with the development of impulse control disorders (ICDs), possibly due to overstimulation of the mesolimbic system by dopaminergic medication. Preliminary reports have suggested that deep brain stimulation (DBS), a neurosurgical procedure offered to...

Full description

Bibliographic Details
Main Authors: Polyvios Demetriades, Hugh Rickards, Andrea Eugenio Cavanna
Format: Article
Language:English
Published: Hindawi Limited 2011-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.4061/2011/658415
id doaj-0cb2bc32d9df4022a401216810031484
record_format Article
spelling doaj-0cb2bc32d9df4022a4012168100314842020-11-24T22:36:50ZengHindawi LimitedParkinson's Disease2042-00802011-01-01201110.4061/2011/658415658415Impulse Control Disorders Following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: Clinical AspectsPolyvios Demetriades0Hugh Rickards1Andrea Eugenio Cavanna2University of Birmingham Medical School, Birmingham B152TT, UKUniversity of Birmingham Medical School, Birmingham B152TT, UKUniversity of Birmingham Medical School, Birmingham B152TT, UKParkinson's disease (PD) has been associated with the development of impulse control disorders (ICDs), possibly due to overstimulation of the mesolimbic system by dopaminergic medication. Preliminary reports have suggested that deep brain stimulation (DBS), a neurosurgical procedure offered to patients with treatment-resistant PD, affects ICD in a twofold way. Firstly, DBS allows a decrease in dopaminergic medication and hence causes an improvement in ICDs. Secondly, some studies have proposed that specific ICDs may develop after DBS. This paper addresses the effects of DBS on ICDs in patients with PD. A literature search identified four original studies examining a total of 182 patients for ICDs and nine case reports of 39 patients that underwent DBS and developed ICDs at some point. Data analysis from the original studies did not identify a significant difference in ICDs between patients receiving dopaminergic medication and patients on DBS, whilst the case reports showed that 56% of patients undergoing DBS had poor outcome with regards to ICDs. We discuss these ambivalent findings in the light of proposed pathogenetic mechanisms. Longitudinal, prospective studies with larger number of patients are required in order to fully understand the role of DBS on ICDs in patients with PD.http://dx.doi.org/10.4061/2011/658415
collection DOAJ
language English
format Article
sources DOAJ
author Polyvios Demetriades
Hugh Rickards
Andrea Eugenio Cavanna
spellingShingle Polyvios Demetriades
Hugh Rickards
Andrea Eugenio Cavanna
Impulse Control Disorders Following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: Clinical Aspects
Parkinson's Disease
author_facet Polyvios Demetriades
Hugh Rickards
Andrea Eugenio Cavanna
author_sort Polyvios Demetriades
title Impulse Control Disorders Following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: Clinical Aspects
title_short Impulse Control Disorders Following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: Clinical Aspects
title_full Impulse Control Disorders Following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: Clinical Aspects
title_fullStr Impulse Control Disorders Following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: Clinical Aspects
title_full_unstemmed Impulse Control Disorders Following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: Clinical Aspects
title_sort impulse control disorders following deep brain stimulation of the subthalamic nucleus in parkinson's disease: clinical aspects
publisher Hindawi Limited
series Parkinson's Disease
issn 2042-0080
publishDate 2011-01-01
description Parkinson's disease (PD) has been associated with the development of impulse control disorders (ICDs), possibly due to overstimulation of the mesolimbic system by dopaminergic medication. Preliminary reports have suggested that deep brain stimulation (DBS), a neurosurgical procedure offered to patients with treatment-resistant PD, affects ICD in a twofold way. Firstly, DBS allows a decrease in dopaminergic medication and hence causes an improvement in ICDs. Secondly, some studies have proposed that specific ICDs may develop after DBS. This paper addresses the effects of DBS on ICDs in patients with PD. A literature search identified four original studies examining a total of 182 patients for ICDs and nine case reports of 39 patients that underwent DBS and developed ICDs at some point. Data analysis from the original studies did not identify a significant difference in ICDs between patients receiving dopaminergic medication and patients on DBS, whilst the case reports showed that 56% of patients undergoing DBS had poor outcome with regards to ICDs. We discuss these ambivalent findings in the light of proposed pathogenetic mechanisms. Longitudinal, prospective studies with larger number of patients are required in order to fully understand the role of DBS on ICDs in patients with PD.
url http://dx.doi.org/10.4061/2011/658415
work_keys_str_mv AT polyviosdemetriades impulsecontroldisordersfollowingdeepbrainstimulationofthesubthalamicnucleusinparkinsonsdiseaseclinicalaspects
AT hughrickards impulsecontroldisordersfollowingdeepbrainstimulationofthesubthalamicnucleusinparkinsonsdiseaseclinicalaspects
AT andreaeugeniocavanna impulsecontroldisordersfollowingdeepbrainstimulationofthesubthalamicnucleusinparkinsonsdiseaseclinicalaspects
_version_ 1725718319798943744